Clinical Trial: Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion
Brief Summary: In this study, we will compare the safety and efficacy of 400 mcg sublingually administered misoprostol alone to standard surgical care for the treatment of incomplete abortion. This study will provide important data on the role of misoprostol in health services offering an array of treatments for incomplete abortion. Women could significantly benefit from a non-invasive treatment option for incomplete abortion. While safe surgical services are becoming more widespread, there is still a serious risk of complications from these procedures. Especially in developing countries, infection, hemorrhage and uterine damage are still too common. Medical treatment of incomplete abortion using misoprostol would be a tremendous step to reducing morbidity and mortality due to abortion complications.
Detailed Summary:
Sponsor: Gynuity Health Projects
Current Primary Outcome: Complete abortion without recourse to surgical intervention. [ Time Frame: follow up visit 7 days after initial treatment ]
Original Primary Outcome: Complete abortion without recourse to surgical intervention.
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Gynuity Health Projects
Dates:
Date Received: April 25, 2007
Date Started: February 2007
Date Completion:
Last Updated: March 28, 2012
Last Verified: March 2012